These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 37291599

  • 1. Moderators of the cost-effectiveness of transdiagnostic CBT for anxiety disorders over an 8-month time horizon using a net-benefit regression framework.
    Chapdelaine A, Vasiliadis HM, Provencher MD, Norton PJ, Roberge P.
    BMC Health Serv Res; 2023 Jun 08; 23(1):596. PubMed ID: 37291599
    [Abstract] [Full Text] [Related]

  • 2. Cost-Effectiveness of Group Transdiagnostic Cognitive Behavioural Therapy for Anxiety Disorders in Primary Care Settings: Economic Evaluation From the Healthcare System Perspective Over a 1-Year Time Horizon.
    Vasiliadis HM, Lamoureux-Lamarche C, Chapdelaine A, Provencher MD, Norton PJ, Berbiche D, Roberge P.
    Can J Psychiatry; 2024 Jan 08; 69(1):43-53. PubMed ID: 37461378
    [Abstract] [Full Text] [Related]

  • 3. A pragmatic randomized controlled trial of group transdiagnostic cognitive-behaviour therapy for anxiety disorders in primary care: study protocol.
    Roberge P, Provencher MD, Gosselin P, Vasiliadis HM, Gaboury I, Benoit A, Antony MM, Chaillet N, Houle J, Hudon C, Norton PJ.
    BMC Psychiatry; 2018 Oct 03; 18(1):320. PubMed ID: 30285672
    [Abstract] [Full Text] [Related]

  • 4. Cost-effectiveness of transdiagnostic group cognitive behavioural therapy for anxiety disorders v. treatment as usual: economic evaluation of a pragmatic randomized controlled trial over an 8-month time horizon using self-reported data.
    Chapdelaine A, Vasiliadis HM, Provencher MD, Norton PJ, Roberge P.
    Psychol Med; 2023 Oct 03; 53(14):6570-6582. PubMed ID: 36695038
    [Abstract] [Full Text] [Related]

  • 5. Therapist telephone-delivered CBT and web-based CBT compared with treatment as usual in refractory irritable bowel syndrome: the ACTIB three-arm RCT.
    Everitt H, Landau S, Little P, Bishop FL, O'Reilly G, Sibelli A, Holland R, Hughes S, Windgassen S, McCrone P, Goldsmith K, Coleman N, Logan R, Chalder T, Moss-Morris R.
    Health Technol Assess; 2019 Apr 03; 23(17):1-154. PubMed ID: 31042143
    [Abstract] [Full Text] [Related]

  • 6. Group transdiagnostic cognitive-behavior therapy for anxiety disorders: a pragmatic randomized clinical trial.
    Roberge P, Provencher MD, Gaboury I, Gosselin P, Vasiliadis HM, Benoît A, Carrier N, Antony MM, Chaillet N, Houle J, Hudon C, Norton PJ.
    Psychol Med; 2020 Dec 02; 52(13):1-11. PubMed ID: 33261700
    [Abstract] [Full Text] [Related]

  • 7. The effectiveness of transdiagnostic cognitive behavioural therapy for anxiety disorders: the role of and impact of comorbid depression.
    George MG, Roberge P, Provencher MD, Norton PJ.
    Cogn Behav Ther; 2024 Jan 02; 53(1):105-118. PubMed ID: 37934006
    [Abstract] [Full Text] [Related]

  • 8. Computerised cognitive behaviour therapy for depression and anxiety update: a systematic review and economic evaluation.
    Kaltenthaler E, Brazier J, De Nigris E, Tumur I, Ferriter M, Beverley C, Parry G, Rooney G, Sutcliffe P.
    Health Technol Assess; 2006 Sep 02; 10(33):iii, xi-xiv, 1-168. PubMed ID: 16959169
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of transdiagnostic cognitive-behavioral group therapy for anxiety disorders and headache in adolescents.
    Sharma P, Mehta M, Sagar R.
    J Anxiety Disord; 2017 Mar 02; 46():78-84. PubMed ID: 27856068
    [Abstract] [Full Text] [Related]

  • 10. Internet-Delivered Cognitive Behavioural Therapy for Major Depression and Anxiety Disorders: A Health Technology Assessment.
    Health Quality Ontario .
    Ont Health Technol Assess Ser; 2019 Mar 02; 19(6):1-199. PubMed ID: 30873251
    [Abstract] [Full Text] [Related]

  • 11. Manualised cognitive-behavioural therapy in treating depression in advanced cancer: the CanTalk RCT.
    Serfaty M, King M, Nazareth I, Moorey S, Aspden T, Tookman A, Mannix K, Gola A, Davis S, Wood J, Jones L.
    Health Technol Assess; 2019 May 02; 23(19):1-106. PubMed ID: 31097078
    [Abstract] [Full Text] [Related]

  • 12. Cost-effectiveness and cost-utility evaluation of individual vs. group transdiagnostic psychological treatment for emotional disorders in primary care (PsicAP-Costs): a multicentre randomized controlled trial protocol.
    Aguilera-Martín Á, Gálvez-Lara M, Cuadrado F, Moreno E, García-Torres F, Venceslá JF, Corpas J, Jurado-González FJ, Muñoz-Navarro R, González-Blanch C, Ruiz-Rodríguez P, Barrio-Martínez S, Prieto-Vila M, Carpallo-González M, Cano-Vindel A, Moriana JA.
    BMC Psychiatry; 2022 Feb 09; 22(1):99. PubMed ID: 35139809
    [Abstract] [Full Text] [Related]

  • 13. Intermittent Motivational Interviewing and Transdiagnostic CBT for Anxiety: A Randomized Controlled Trial.
    Marker I, Corbett BE, Drummond SPA, Norton PJ.
    J Anxiety Disord; 2020 Oct 09; 75():102276. PubMed ID: 32768874
    [Abstract] [Full Text] [Related]

  • 14. Cost effectiveness of therapist delivered cognitive behavioural therapy and web-based self-management in irritable bowel syndrome: the ACTIB randomised trial.
    McCrone P, Everitt H, Landau S, Little P, Bishop FL, O'Reilly G, Sibelli A, Holland R, Hughes S, Windgassen S, Goldsmith K, Coleman N, Logan R, Chalder T, Moss-Morris R.
    BMC Gastroenterol; 2021 Jul 06; 21(1):276. PubMed ID: 34229619
    [Abstract] [Full Text] [Related]

  • 15. Cost-effectiveness of transdiagnostic group cognitive behavioural therapy versus group relaxation therapy for emotional disorders in primary care (PsicAP-Costs2): Protocol for a multicentre randomised controlled trial.
    González-Blanch C, Barrio-Martínez S, Priede A, Martínez-Gómez S, Pérez-García-Abad S, Miras-Aguilar M, Ruiz-Gutiérrez J, Muñoz-Navarro R, Ruiz-Rodríguez P, Medrano LA, Prieto-Vila M, Carpallo-González M, Aguilera-Martín Á, Gálvez-Lara M, Cuadrado F, Moreno E, García-Torres F, Venceslá JF, Corpas J, Jurado-González FJ, Moriana JA, Cano-Vindel A.
    PLoS One; 2023 Jul 06; 18(3):e0283104. PubMed ID: 36928238
    [Abstract] [Full Text] [Related]

  • 16. Impact of group transdiagnostic cognitive-behavior therapy for anxiety disorders on comorbid diagnoses: Results from a pragmatic randomized clinical trial in primary care.
    Norton PJ, Provencher MD, Kilby CJ, Roberge P.
    Depress Anxiety; 2021 Jun 18. PubMed ID: 34142748
    [Abstract] [Full Text] [Related]

  • 17. An analysis of differential improvement by diagnosis in group transdiagnostic cognitive behaviour therapy for anxiety disorders.
    Rostami M, Provencher MD, Roberge P, Norton PJ.
    J Ment Health; 2023 Jun 18; 32(3):619-624. PubMed ID: 36840371
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of transdiagnostic cognitive behaviour therapy for anxiety disorders: a systematic review and meta-analysis of published outcome studies.
    Reinholt N, Krogh J.
    Cogn Behav Ther; 2014 Jun 18; 43(3):171-84. PubMed ID: 24646219
    [Abstract] [Full Text] [Related]

  • 19. Psychotherapy for Major Depressive Disorder and Generalized Anxiety Disorder: A Health Technology Assessment.
    Health Quality Ontario .
    Ont Health Technol Assess Ser; 2017 Jun 18; 17(15):1-167. PubMed ID: 29213344
    [Abstract] [Full Text] [Related]

  • 20. START (STrAtegies for RelaTives) study: a pragmatic randomised controlled trial to determine the clinical effectiveness and cost-effectiveness of a manual-based coping strategy programme in promoting the mental health of carers of people with dementia.
    Livingston G, Barber J, Rapaport P, Knapp M, Griffin M, Romeo R, King D, Livingston D, Lewis-Holmes E, Mummery C, Walker Z, Hoe J, Cooper C.
    Health Technol Assess; 2014 Oct 18; 18(61):1-242. PubMed ID: 25300037
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.